NFKB1 and inflammatory bowel disease: Increased activation of NF-κB has been observed in colonic mucosa from IBD patients, leading to the up-regulation of pro-inflammatory cytokines (e.g., TNF-α, IL-1β, IL-6), adhesion molecules and inflammatory mediators [62].